Table 1.

Clinical Characteristics of 11 Patients Treated with Convalescent Plasma in 2 Studies

Study and Patient No.SexAge, yTime From Symptom Onset to Plasma Transfusion, dRespiratory FailureConvalescent Plasma Treatments, No.Convalescent Plasma Dosage, mLSurvival
Shen et al [6]
1Male7324Yes1400Yes
2Male6014Yes1400Yes
3Female5022Yes1400Yes
4Female3621Yes1400Yes
5Male6023Yes1400Yes
1Male3213Yes1200Yes
Zeng et al [10]
2Female3026Yes2600No
3Male7633Yes2400No
4Male6130Yes2600No
5Male6223Yes1200No
6Male8330Yes1200No
Study and Patient No.SexAge, yTime From Symptom Onset to Plasma Transfusion, dRespiratory FailureConvalescent Plasma Treatments, No.Convalescent Plasma Dosage, mLSurvival
Shen et al [6]
1Male7324Yes1400Yes
2Male6014Yes1400Yes
3Female5022Yes1400Yes
4Female3621Yes1400Yes
5Male6023Yes1400Yes
1Male3213Yes1200Yes
Zeng et al [10]
2Female3026Yes2600No
3Male7633Yes2400No
4Male6130Yes2600No
5Male6223Yes1200No
6Male8330Yes1200No
Table 1.

Clinical Characteristics of 11 Patients Treated with Convalescent Plasma in 2 Studies

Study and Patient No.SexAge, yTime From Symptom Onset to Plasma Transfusion, dRespiratory FailureConvalescent Plasma Treatments, No.Convalescent Plasma Dosage, mLSurvival
Shen et al [6]
1Male7324Yes1400Yes
2Male6014Yes1400Yes
3Female5022Yes1400Yes
4Female3621Yes1400Yes
5Male6023Yes1400Yes
1Male3213Yes1200Yes
Zeng et al [10]
2Female3026Yes2600No
3Male7633Yes2400No
4Male6130Yes2600No
5Male6223Yes1200No
6Male8330Yes1200No
Study and Patient No.SexAge, yTime From Symptom Onset to Plasma Transfusion, dRespiratory FailureConvalescent Plasma Treatments, No.Convalescent Plasma Dosage, mLSurvival
Shen et al [6]
1Male7324Yes1400Yes
2Male6014Yes1400Yes
3Female5022Yes1400Yes
4Female3621Yes1400Yes
5Male6023Yes1400Yes
1Male3213Yes1200Yes
Zeng et al [10]
2Female3026Yes2600No
3Male7633Yes2400No
4Male6130Yes2600No
5Male6223Yes1200No
6Male8330Yes1200No
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close